Aoxing Pharmaceutical Company, Inc. (AOXG)
OTCMKTS: AOXG · Delayed Price · USD
0.0051
0.00 (0.00%)
Apr 12, 2024, 1:28 PM EDT - Market closed

AOXG Income Statement

Millions USD. Fiscal year is Jul - Jun.
Year 2023202220212020201920162015201420132012 2011 - 2005
Revenue
0000032.3325.4812.7410.838.13
Upgrade
Revenue Growth (YoY)
-----26.88%100.02%17.63%33.14%22.30%
Upgrade
Cost of Revenue
000007.785.696.934.563.23
Upgrade
Gross Profit
0000024.5519.795.816.274.9
Upgrade
Selling, General & Admin
0000014.6810.217.9610.754.88
Upgrade
Research & Development
000003.140.340.571.480.58
Upgrade
Other Operating Expenses
000000.20000
Upgrade
Operating Expenses
0000018.3311.19.1512.826.05
Upgrade
Operating Income
000006.238.7-3.33-14.22-14.55
Upgrade
Interest Expense
0000000001.86
Upgrade
Other Expense / Income
-----3.525.910.1-7.56-2.26
Upgrade
Pretax Income
000002.893.11-8.63-17.29-15.88
Upgrade
Income Tax
000000.64-2.74.7810.141.67
Upgrade
Net Income
000002.065.49-8.22-16.8-15.82
Upgrade
Net Income Growth
------62.49%----
Upgrade
Shares Outstanding (Basic)
-----7463505049
Upgrade
Shares Outstanding (Diluted)
-----7563505049
Upgrade
Shares Change
-----19.47%26.70%0.21%0.82%5.94%
Upgrade
EPS (Basic)
-----0.030.09-0.16-0.34-0.32
Upgrade
EPS (Diluted)
-----0.030.09-0.16-0.34-0.32
Upgrade
EPS Growth
------66.67%----
Upgrade
Free Cash Flow
00000-0.650.32-8-8.76-2.08
Upgrade
Free Cash Flow Per Share
------0.010.01-0.16-0.18-0.04
Upgrade
Gross Margin
-----75.95%77.67%45.64%57.87%60.24%
Upgrade
Operating Margin
-----19.26%34.13%-26.18%-131.32%-178.86%
Upgrade
Profit Margin
-----6.38%21.56%-64.49%-155.17%-194.49%
Upgrade
Free Cash Flow Margin
------2.02%1.26%-62.79%-80.86%-25.55%
Upgrade
Effective Tax Rate
-----22.26%-86.84%---
Upgrade
EBITDA
000007.259.08-2.342.21-0.2
Upgrade
EBITDA Margin
-----22.44%35.64%-18.41%20.36%-2.49%
Upgrade
Depreciation & Amortization
000001.030.670.991.111.08
Upgrade
EBIT
-----6.238.42-3.331.09-1.28
Upgrade
EBIT Margin
-----19.26%33.03%-26.18%10.07%-15.76%
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.